FDA Inspection
Sabine S. Hazan, M.D.Sabine S. Hazan, M.D. – FDA Inspection, Sep 21, 2021
Record Details
This FDA Inspection record concerns Sabine S. Hazan, M.D., with an inspection on September 21, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Sabine S. Hazan, M.D.
- Inspection Date
- September 21, 2021
- Product Type
- Biologics
View Company Profile
ID · a03032c0-8473-4393-8244-3b55eb189b53
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1153137
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
- Enforcement
- Warning Letter
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.60Informed consent
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sabine S. Hazan, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2024 | Not classified | Los Angeles District Office |
Other documents for Sabine S. Hazan, M.D.
- FDA Inspection 1251559 - 2024-09-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.